Alterity Therapeutics Investor Relations Material
Latest events
Study Result
Alterity Therapeutics
Q3 2025 TU
29 Apr, 2025
H1 2025
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alterity Therapeutics Limited
Access all reports
Alterity Therapeutics Limited is a biotechnology company focused on developing therapies for neurodegenerative diseases. The company specializes in small molecule treatments designed to target underlying biological processes associated with disorders such as Parkinsons and other neurological conditions. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Key slides for Alterity Therapeutics Limited
Corporate Presentation
Alterity Therapeutics Limited
Study Result
Alterity Therapeutics Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ATH
Country
🇦🇺 Australia